Ryan Lirette
Physical Medicine & Rehabilitation · Lawrenceville, GANPI 1992159842
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,921 of the $6,366 with a category attached, or 77.3%. 18 manufacturers reported payments, led by Medtronic at 42.8% of the total. 2025 is the largest year on record at $2,433, more than ten times the $94 reported in 2019. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $59.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Nevro Corp.$1K
- Abbott$904
- Boston Scientific$534
- Globus Medical$368
- Biotronik NRO, Inc.$156
- plus $489 from 12 others
What the payments were for
- Travel & lodging$1,44523%
- Food & beverage$4,92177%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 36 | $2,727 |
| Nevro Corp. | 22 | $1,187 |
| Abbott | 9 | $904 |
| Boston Scientific | 11 | $534 |
| Globus Medical | 6 | $368 |
| Biotronik NRO, Inc. | 1 | $156 |
| Vertex | 2 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Johnson & Johnson | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Forte Bio-pharma LLC | 2 | $33 |
| Biodelivery Sciences International, Inc. | 2 | $33 |
| AbbVie | 2 | $29 |
| Endo USA, Inc. | 1 | $25 |
| GRT US Holding, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,243
- Senza$503
- Proclaim IPG$437
- Omnia$336
- INTELLIS ADAPTIVESTIM$280
- Hedron$166
- Prospera$156
- PROCLAIM$140
- CLINICAL TRIAL PRODUCT$115
- INTELLIS$111
- SPECTRA WAVEWRITER$109
How this compares
$6,366 in reported general payments places this provider in the 90th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 12 | $27,279 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 436 | $13,569 |
| Xtampza ErOxycodone Myristate | 21 | $11,723 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 306 | $5,406 |
| Oxycodone Hcl | 169 | $3,551 |
| Gabapentin | 308 | $3,310 |
| Pregabalin | 110 | $1,598 |
| Tizanidine Hcl | 242 | $1,573 |
| Lidocaine | 15 | $1,119 |
| Diclofenac Sodium | 23 | $1,078 |
| Celecoxib | 47 | $999 |
| Tramadol Hcl | 218 | $756 |
| Duloxetine Hcl | 59 | $697 |
| Morphine Sulfate | 26 | $667 |
| Ondansetron OdtOndansetron | 25 | $618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $84 | $27,27912 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $20 | $11,72321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 214 physical medicine & rehabilitation providers in Georgia.
Other physical medicine & rehabilitation in Lawrenceville
- Gerald ChaiLawrenceville$16K
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
- Joseph HegartyBaxley$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.